Marc Lerchenmüller is Assistant Professor of Technological Innovation and Management at the University of Mannheim. Prof. Lerchenmüller is also engaged at the Center for European Economic Research (ZEW).
His research is primarily concerned with economic incentive systems and the associated strategic decisions for actors in innovative sectors. In a second research program, he deals with science policy and the translation of academic knowledge. His research has appeared in the bmj, Circulation, Nature Communications and Research Policy, among others, and has received international attention in media such as The Economist, the New York Times and the Frankfurter Allgemeine Zeitung.
Prof. Lerchenmüller supported the European Commission as a scientific expert on the impact of the Covid crisis on science and is active in international scientific advisory boards.
Prior to his academic career, Prof. Lerchenmüller worked for the Boston Consulting Group in New York and was a founding member of InoCard – a biotechnology start-up – that was successfully sold to uniQure in 2014 and entered into a development alliance with Bristol-Myers Squibb. With AaviGen, he is pursuing a second start-up in the field of gene therapy.
Prof. Lerchenmüller is an alumnus of Imperial College London, the London School of Hygiene and Tropical Medicine, Oxford University, WHU and Yale University.
For further information, please visit Marc Lerchenmüller's homepage.